Alkem Laboratories Limited
ALKEM
Rangering i aksjer
#2813
Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in... Alkem Laboratories Ltd. functions as a pharmaceutical enterprise, engaged in the research, manufacturing, and worldwide distribution of both medicinal and nutritional products. Its comprehensive offerings encompass a variety of branded and generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceuticals. These products target both immediate and chronic health issues across numerous therapeutic areas, including anti-infectives, skin conditions, cardiovascular health, respiratory ailments, digestive problems, central nervous system disorders, cancer, urology, and women's health. The company also provides essential vitamins, minerals, and nutritional supplements, in addition to pain relief medications, anti-diabetic treatments, and neurological remedies. Complementing its core pharmaceutical lines, Alkem offers consumer health items such as pregnancy detection kits and condoms. Founded in 1973, the company's headquarters are located in Mumbai, India.
Aksjekurs
$55.19
Markedsverdi
$6.60B
Endring (1 dag)
-0.06%
Endring (1 år)
-12.43%
Land
IN
Handel Alkem Laboratories Limited (ALKEM)
Kategori
Healthcare
P/B-forhold for Alkem Laboratories Limited (ALKEM)
P/B-forhold per October 2026 TTM: 4.31
Ifølge Alkem Laboratories Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/B-forhold (TTM) 4.31. Ved slutten av 2024 hadde selskapet et P/B-forhold på 5.81.
P/B-historikk for Alkem Laboratories Limited fra 2010 til 2026
P/B-forhold ved hvert års slutt
| År | P/B-forhold | Endre |
|---|---|---|
| 2026 (TTM) | 4.31 | -10.49% |
| 2025 | 4.82 | -16.94% |
| 2024 | 5.81 | 29.38% |
| 2023 | 4.49 | -10.43% |
| 2022 | 5.01 | 11.63% |
| 2021 | 4.49 | -0.54% |
| 2020 | 4.51 | 17.52% |
| 2019 | 3.84 | -18.59% |
| 2018 | 4.72 | -20.04% |
| 2017 | 5.90 | 34.33% |
| 2016 | 4.39 | -20.25% |
| 2015 | 5.51 | -11.47% |
| 2014 | 6.22 | -10.59% |
| 2013 | 6.96 | -19.73% |
| 2012 | 8.67 | -25.08% |
| 2011 | 11.57 | -15.57% |
| 2010 | 13.71 | 0.00% |
P/B-forhold for lignende selskaper eller konkurrenter
| Selskap | P/B-forhold | Forskjell i P/B-forhold | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| 5.041 | 16.85% |
IN
|
